has received research funding from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Coherus Biosciences, Dermira, Eli Lilly, Janssen, Merck, Novartis, Pfizer, Regeneron, Sandoz and Sun Pharmaceuticals
Br J Cancer 99 : 911922
By competitively binding to p53, FOXO4-DRI displaces endogenous FOXO4, causing p53 nuclear exclusion and translocation to mitochondria where it triggers the intrinsic apoptotic pathway through caspase-3/7 activation
miR-192 is highly expressed in the liver, where it regulates liver development, cellular transdifferentiation, and energy metabolism [313]
There's nothing quite like a community that cheers you on
Gp phn lm m sm nm, tn nhang: H tr lm gim tnh trng da khng u mu v cc m sc t